Hikari Power LTD Tg Therapeutics, Inc. Transaction History

Hikari Power LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 07, 2021	SELL	$32.5 - $48.96 $162,500 - $244,800	-5,000 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$25.27 - $54.9 $126,350 - $274,500	5,000 New	5,000 $260,000
Q3 2020 Oct 08, 2020	SELL	$18.49 - $27.24 $184,899 - $272,400	-10,000 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$7.14 - $15.99 $71,400 - $159,900	10,000 New	10,000 $98,000
Q4 2019 Feb 04, 2020	SELL	$5.1 - $11.2 $254,999 - $560,000	-50,000 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$3.44 - $5.76 $378,400 - $633,600	-110,000 Reduced 68.75%	50,000 $205,000
Q3 2017 Nov 08, 2017	BUY	$10.0 - $12.7 $1 Million - $1.27 Million	100,000 Added 166.67%	160,000 $1.9 Million
Q2 2017 Aug 09, 2017	BUY	N/A	60,000	60,000 $603,000

287

91.8M

1.9M

1.45M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.4B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

Stay updated on Hikari Power LTD with notifications on news.